Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Works of Farida Souami being referenced
Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Farida Souami | 155 | 170 | 21 | 68 | 7 | 256 | |
| Elke Burger | 64 | 161 | 40 | 119 | 11 | 310 | |
| Maria Grazia Mameli | 134 | 113 | 42 | 48 | 11 | 299 | |
| Sudha Rao | 98 | 47 | 17 | 31 | 9 | 232 | |
| Hal Hirte | 43 | 139 | 26 | 49 | 9 | 309 | |
| Shahin Shajahan | 130 | 63 | 27 | 44 | 9 | 311 | |
| Federica Predolini | 49 | 143 | 10 | 35 | 12 | 267 | |
| Erik Asmus | 38 | 93 | 17 | 36 | 9 | 168 | |
| Katherine Lane | 66 | 187 | 23 | 99 | 6 | 300 | |
| Clare Bartos | 39 | 69 | 26 | 62 | 11 | 228 | |
| D. Castéra | 143 | 157 | 32 | 85 | 9 | 289 |
All Works
Loading papers...